Sabra Health Care REIT (SBRA) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Closed $599 million in senior housing and skilled nursing investments year-to-date, with a robust pipeline exceeding $1 billion, primarily in managed senior housing, and a focus on quality care, operational expertise, and portfolio diversification.
Managed Senior Housing portfolio saw sequential revenue growth of 9.6% and cash NOI growth of 14.4%, with margin expansion of 130 basis points; same property managed senior housing Cash NOI increased 13.7% year-over-year.
Portfolio expanded to 395 investments as of June 30, 2026, with significant acquisitions and select asset sales, and a 7-year weighted average remaining lease term.
Net loss attributable to shareholders was $25.2 million for Q2 2026, with normalized FFO of $0.38 and normalized AFFO of $0.40 per share.
Emphasis on sustainability, technology adoption, and diversity to enhance operational efficiency and stakeholder value.
Financial highlights
Total revenues for Q2 2026 were $235.9 million, up from $189.2 million in Q2 2025; normalized FFO for Q2 2026 was $98.2 million ($0.38 per share), and normalized AFFO was $103.5 million ($0.40 per share).
Cash NOI from managed senior housing was $44.6 million, up from $39 million last quarter; total cash NOI for the quarter was $144.3 million.
Dividend of $0.30 per share declared for Q2 2026, with $151.3 million paid in dividends in the first half.
Recorded a $102.4 million provision for loan losses, primarily related to the discounted payoff of the RCA Mortgage Loan.
Interest expense increased to $29.8 million in Q2 2026 from $27.5 million in Q2 2025.
Outlook and guidance
Reaffirmed 2026 guidance, projecting 7% year-over-year growth in normalized FFO per share and 8% in normalized AFFO per share, with low to mid-teens same-store SHOP NOI growth.
Pipeline includes an additional $100 million in managed senior housing and skilled nursing investments expected to close by year-end, with an estimated initial cash yield of 7.7%.
Management expects continued portfolio growth and diversification through acquisitions and select asset sales.
General and administrative expenses expected at $61 million, including $13 million stock-based compensation.
Sufficient liquidity is expected for the next twelve months, with $1.3 billion in liquidity as of June 30, 2026.
Latest events from Sabra Health Care REIT
- Q1 2026 saw strong earnings, robust investments, and reaffirmed guidance for continued growth.SBRA
Q1 2026 - Proxy covers director elections, auditor ratification, and performance-based executive pay.SBRA
Proxy filing - Annual meeting seeks votes on directors, auditor, and executive pay, all board-recommended.SBRA
Proxy filing - Q4 2025 saw strong managed senior housing growth and robust 2026 guidance for ~5% FFO/AFFO growth.SBRA
Q4 2025 - Director elections, auditor ratification, and executive pay highlight strong governance and ESG.SBRA
Proxy Filing - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SBRA
Proxy Filing - Q3 2024 saw strong earnings, raised guidance, and robust liquidity amid sector growth.SBRA
Q3 2024 - 2024 guidance raised as managed senior housing and FFO/AFFO growth accelerate.SBRA
Q2 2024 - Q4 2024 saw strong managed senior housing growth, improved leverage, and a positive 2025 outlook.SBRA
Q4 2024